Vanguard Group’s Conformis, Inc. Common Stock CFMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-107,469
| Closed | -$235K | – | 4641 |
|
|
2023
Q2 | $235K | Sell |
107,469
-188,201
| -64% | -$267K | ﹤0.01% | 4285 |
|
|
2023
Q1 | $476K | Hold |
295,670
| – | – | ﹤0.01% | 4135 |
|
|
2022
Q4 | $982K | Buy |
295,670
+154
| +0.1% | +$478 | ﹤0.01% | 3923 |
|
|
2022
Q3 | $1.41M | Sell |
295,516
-28,123
| -9% | -$195K | ﹤0.01% | 3882 |
|
|
2022
Q2 | $2.86M | Hold |
323,639
| – | – | ﹤0.01% | 3649 |
|
|
2022
Q1 | $5.05M | Sell |
323,639
-1,276
| -0.4% | -$21K | ﹤0.01% | 3523 |
|
|
2021
Q4 | $6.18M | Sell |
324,915
-3,322
| -1% | -$85.1K | ﹤0.01% | 3492 |
|
|
2021
Q3 | $10.9M | Buy |
328,237
+568
| +0.2% | +$20K | ﹤0.01% | 3189 |
|
|
2021
Q2 | $9.42M | Buy |
327,669
+31,360
| +11% | +$741K | ﹤0.01% | 3237 |
|
|
2021
Q1 | $7.33M | Buy |
296,309
+169,541
| +134% | +$4.57M | ﹤0.01% | 3329 |
|
|
2020
Q4 | $2.09M | Buy |
126,768
+4,695
| +4% | +$81K | ﹤0.01% | 3650 |
|
|
2020
Q3 | $2.56M | Sell |
122,073
-749
| -0.6% | -$14.3K | ﹤0.01% | 3415 |
|
|
2020
Q2 | $2.52M | Sell |
122,822
-9,783
| -7% | -$205K | ﹤0.01% | 3363 |
|
|
2020
Q1 | $2.09M | Sell |
132,605
-405
| -0.3% | -$9.9K | ﹤0.01% | 3298 |
|
|
2019
Q4 | $4.99M | Buy |
133,010
+2,609
| +2% | +$124K | ﹤0.01% | 3169 |
|
|
2019
Q3 | $6.06M | Buy |
130,401
+10,356
| +9% | +$623K | ﹤0.01% | 3064 |
|
|
2019
Q2 | $13.1M | Buy |
120,045
+40,588
| +51% | +$3.34M | ﹤0.01% | 2708 |
|
|
2019
Q1 | $5.72M | Buy |
79,457
+45,918
| +137% | +$1.31M | ﹤0.01% | 3092 |
|
|
2018
Q4 | $300K | Sell |
33,539
-55,671
| -62% | -$936K | ﹤0.01% | 3825 |
|
|
2018
Q3 | $2.36M | Buy |
89,210
+1,142
| +1% | +$31K | ﹤0.01% | 3473 |
|
|
2018
Q2 | $2.75M | Buy |
88,068
+5,488
| +7% | +$190K | ﹤0.01% | 3402 |
|
|
2018
Q1 | $2.99M | Buy |
82,580
+17,913
| +28% | +$752K | ﹤0.01% | 3326 |
|
|
2017
Q4 | $3.85M | Buy |
64,667
+9,696
| +18% | +$775K | ﹤0.01% | 3231 |
|
|
2017
Q3 | $4.84M | Sell |
54,971
-8,310
| -13% | -$823K | ﹤0.01% | 3132 |
|
|
2017
Q2 | $6.79M | Sell |
63,281
-22,925
| -27% | -$2.75M | ﹤0.01% | 2962 |
|
|
2017
Q1 | $11.3M | Sell |
86,206
-16,042
| -16% | -$2.71M | ﹤0.01% | 2708 |
|
|
2016
Q4 | $20.7M | Buy |
102,248
+8,481
| +9% | +$1.88M | ﹤0.01% | 2409 |
|
|
2016
Q3 | $23.3M | Buy |
93,767
+19,093
| +26% | +$3.84M | ﹤0.01% | 2297 |
|
|
2016
Q2 | $13.1M | Buy |
74,674
+17,773
| +31% | +$4.18M | ﹤0.01% | 2516 |
|
|
2016
Q1 | $15.3M | Buy |
56,901
+30,147
| +113% | +$7.98M | ﹤0.01% | 2402 |
|
|
2015
Q4 | $11.6M | Buy |
26,754
+2,812
| +12% | +$1.41M | ﹤0.01% | 2560 |
|
|
2015
Q3 | $10.8M | Buy |
+23,942
| New | +$12.1M | ﹤0.01% | 2571 |
|
Other funds holding CFMS
Vanguard Group's CFMS Position: Q3 2023 in Review
Vanguard Group sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2023, closing a stake of 107,469 shares — an estimated $235K sold.
Vanguard Group first reported a position in CFMS in Q3 2015 and held it in 32 quarters. The position peaked at $23.3M in Q3 2016. 1 fund tracked by Wall St. Rank holds CFMS as of Q3 2023.
- Vanguard Group reported no remaining Conformis, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Vanguard Group sold 107,469 Conformis, Inc. Common Stock shares in Q3 2023, an estimated $235K.
- Vanguard Group first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 32 quarters.
- Vanguard Group's Conformis, Inc. Common Stock position peaked at $23.3M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2023.
Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.